Targeting Toxoplasma Gondii Latent Stages Responsible for Chronic Disease

Abstract

Many microbial pathogens become resistant to host immune response and drugs by entering a slow-growing, dormant state. These stages are commonly responsible for long term, chronic infections. We will investigate the molecular basis of dormancy in Toxoplasma gondii, which infects one in three people. These studies will identify metabolic pathways that are essential for dormancy with the view of developing new therapies for treating long term, recurrent infections.

Related publications (1)

Regulation of Starch Stores by a Ca2 -Dependent Protein Kinase Is Essential for Viable Cyst Development in Toxoplasma gondii

AD Uboldi, JM McCoy, M Blume, M Gerlic, DJP Ferguson, LF Dagley, CT Beahan, DI Stapleton, PR Gooley, A Bacic, SL Masters, AI Webb, MJ McConville, CJ Tonkin

2015-12-01

Summary Transmissible stages of Toxoplasma gondii store energy in the form of the carbohydrate amylopectin. Here, we show that the..